Denali therapeutics inc reports qtrly net loss of $56.8 mln

Denali therapeutics reports first quarter 2020 financial results and provides covid-19 response update.denali therapeutics inc - for three months ended march 31, 2020, denali reported a net loss of $56.8 million.denali therapeutics inc - collaboration revenue was $3.6 million for three months ended march 31, 2020.

DNLI Ratings Summary

DNLI Quant Ranking